Obese subjects present higher risk of developing mammary tumors, worse disease free survival and altered response to neoadjuvant chemotherapy (NAC). The circulating levels of the apelin adipokines are increased in obese subjects and are associated with poorer prognosis in cancer patients. In this study, we showed that obesity and tumoral apelin expression are two factors associated with incomplete response to NAC in breast cancer patients.